Market Alert: S&P/ASX 200 Nearing All - Time High – Tactical Positioning Advised Amid Geopolitical Tensions

Lakes Blue Energy Secures $6.5 Million to Fund Drilling Operations

Jun 17, 2025

Highlights:

  • $6.5 Million Raised: Lakes Blue Energy NL (ASX: LKO) secured $6.5 million through a two-tranche placement to fully fund drilling at its Wombat 5 appraisal well in PRL 2.
  • Cash Runway Extended: The placement provides working capital through to 30 June 2026, bringing the company’s pro forma cash balance to approximately $9.4 million at the time of writing.
  • Discounted Share Price: Shares are issued at $0.75 each — a 25% discount to the last traded price of $1.00 before trading suspension — with director participation and shareholder approval involved in the second tranche.

Strategic Funding to Advance Key Exploration

Lakes Blue Energy NL (ASX: LKO) has announced it has received firm commitments to raise approximately $6.5 million through a placement, which will enable the company to fully fund the drilling and testing of the Wombat 5 appraisal well in Petroleum Retention Lease 2 (PRL 2). At the time of writing, the placement will result in an estimated pro forma cash position of around $9.4 million, ensuring sufficient working capital through to 30 June 2026.

Placement Structure and Shareholder Participation

The capital raise is being executed in two tranches. Tranche One, totalling $5,995,250.25, involves the issue of 7,993,667 shares and will utilise the company’s existing placement capacity under ASX Listing Rule 7.1. These shares are expected to be issued following Lakes Blue Energy's reinstatement to trading on the ASX. Tranche Two aims to raise an additional $502,500.00 through the issue of 670,000 shares, subject to shareholder approval at a General Meeting scheduled around 22 July 2025, with issuance anticipated on or around 24 July 2025.

Director Involvement and Pricing Details

Directors of the company intend to participate in the placement, applying up to $636,024 in outstanding remuneration, pending shareholder approval. Shares will be issued at $0.75 per share — a 25% discount to the last traded price of $1.00 before the company's suspension from quotation on 2 October 2023.

Advisory and Management

Morgans Financial Limited acted as the Lead Manager for the placement and has also underwritten the offering. The company has formalised this through a Placement and Underwriting Agreement, ensuring strong financial backing for its next phase of operations.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com